Terrace Pharmaceuticals

Terrace Pharmaceuticals is a private biotechnology company based in South San Francisco, California, focused on the discovery and development of novel small molecule therapeutics. The company was founded by Kevin Judice, the former CEO of DiCE Molecules, following that company's $2.4 billion acquisition by Eli Lilly. Terrace operates primarily in stealth mode, leveraging a sophisticated drug discovery platform to target high-value pathways in immunology and inflammation. Supported by significant financing from prominent life science investors, the company is advancing a pipeline of oral medicines designed to address unmet needs in chronic inflammatory conditions. Terrace aims to translate complex biological insights into transformative treatments through rigorous medicinal chemistry and clinical strategy.